SCHEMBL2535752

SCHEMBL2535752

C=CCNCC(O)C(O)CNCC=C

nearest known ligand 0.54

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.34
TSHR P16473 2/20 0.33
ALDH1A1 P00352 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.31
MAPT P10636 1/20 0.31
KDM4E B2RXH2 1/20 0.30
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10818774 0.83 ACHE (0.41) ACHETSHRALDH1A1SMN1; SMN2MAPT
SCHEMBL1007134 0.83
SCHEMBL11454828 0.82 KDM4E (0.43) ACHEKDM4E
SCHEMBL8781841 0.82 KDM4E (0.48) ACHEKDM4E
SCHEMBL4278680 0.82 KDM4E (0.48) ACHEKDM4E
Bromide SCHEMBL11554860 0.81
SCHEMBL8521269 0.81
Hydrochloric Acid SCHEMBL15512214 0.81 ACHE (0.40) ACHETSHRALDH1A1SMN1; SMN2MAPT
Hydrochloric Acid SCHEMBL29086935 0.81
SCHEMBL6934467 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120122760-A1 NOVEL LIPIDS FOR TRANSFECTION OF NUCLEIC ACIDS THOMPSON, PATRICK R. 2012-05-17 US disclosed
US-8034977-B2 Lipids for transfection of nucleic acids MOLECULAR TRANSFER, INC. (US) 2011-10-11 US disclosed
US-20090215067-A1 NOVEL LIPIDS FOR TRANSFECTION OF NUCLEIC ACIDS MOLECULAR TRANSFER, INC. (US) 2009-08-27 US disclosed
US-7531693-B2 Lipids for transfection of nucleic acids MOLECULAR TRANSFER, INC. (US) 2009-05-12 US disclosed
EP-1628647-A4 NOVEL LIPIDS FOR TRANSFECTION OF NUCLEIC ACIDS MOLECULAR TRANSFER INC (US) 2007-10-24 EP disclosed
EP-1628647-A2 NOVEL LIPIDS FOR TRANSFECTION OF NUCLEIC ACIDS Molecular Transfer, Inc. (US) 2006-03-01 EP disclosed
US-20050014962-A1 Novel lipids for transfection of nucleic acids THOMPSON AND PATRICIA A THOMPSON AS TRUSTEES OF THE THOMPSON FAMILY TRUST DATED AUGUST 27 2002, JOHN D. 2005-01-20 US disclosed
WO-2004105697-A2 NOVEL LIPIDS FOR TRANSFECTION OF NUCLEIC ACIDS MOLECULAR TRANSFER, INC. (US) 2004-12-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014962-A1 Novel lipids for transfection of nucleic acids ABHD16A, MBOAT7, NPC1L1 ACHE 4881/4885TSHR 3393/4885ALDH1A1 4821/4885
US-20090215067-A1 NOVEL LIPIDS FOR TRANSFECTION OF NUCLEIC ACIDS ABHD16A, MBOAT7, NPC1L1 ACHE 4881/4885TSHR 3393/4885ALDH1A1 4821/4885
US-20120122760-A1 NOVEL LIPIDS FOR TRANSFECTION OF NUCLEIC ACIDS ABHD16A, MBOAT7, NPC1L1 ACHE 4881/4885TSHR 3393/4885ALDH1A1 4821/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.